Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Anus Neoplasms × regorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Gastrointestinal 1

Conditions

Colorectal Neoplasms 4 Rectal Neoplasms 2 Small Cell Lung Carcinoma 1 Sarcoma 1 Metastatic Solid Malignancies 1 Mesothelioma, Malignant 1 Colonic Neoplasms 1 Anus Neoplasms 1

Interventions

tislelizumab 1 regorafenib 1 Sentinel Lymph Node Biopsy 1 Magnetic Resonance Spectroscopy 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05582031 2023-06-07

REFIT-MSS

Translational Research in Oncology

Phase 2 Withdrawn

GastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Anus Neoplasms, Sarcoma, Colorectal Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡